Skip to main content
Clinical Trials/NCT05656651
NCT05656651
Active, not recruiting
Phase 2

ACTIVE- Acute Effects of a Single Physical Exercise Intervention on Immune Cells and Inflammation in Cancer Patients and a Healthy Comparison Group

Universität Duisburg-Essen1 site in 1 country60 target enrollmentDecember 19, 2022
ConditionsCancer

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Cancer
Sponsor
Universität Duisburg-Essen
Enrollment
60
Locations
1
Primary Endpoint
Number of Natural Killer Cells
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

The aim of the study is to evaluate and compare immune response to a single exercise intervention in cancer patients and healthy age-maged individuals.

Registry
clinicaltrials.gov
Start Date
December 19, 2022
End Date
July 2025
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Miriam Götte

Principal Investigator

Universität Duisburg-Essen

Eligibility Criteria

Inclusion Criteria

  • Adolescents and young adults \>14 years of age
  • undergoing acute cancer treatment (chemotherapy)
  • signed informed consent

Exclusion Criteria

  • Inability to follow and implement test instructions
  • medical contraindication to HIIT on cycle ergometer
  • chemotherapeutic treatment 48 h prior
  • Hb \<8g/dl; platelets \< 20,000/ul.

Outcomes

Primary Outcomes

Number of Natural Killer Cells

Time Frame: Change from pre Intervention to immediately after intervention and 1 hour post intervention

NK cells, subgroups and innate lymphoid cells

Secondary Outcomes

  • Fatigue(Once after intervention)
  • Subjective Quality of Life(Once after intervention)
  • Nutritional status(Once after intervention)

Study Sites (1)

Loading locations...

Similar Trials